Cargando…

Serum ESPL1 Can Be Used as a Biomarker for Patients With Hepatitis B Virus-Related Liver Cancer: A Chinese Case-Control Study

AIMS: To investigate the feasibility of serum extra spindle pole bodies-like 1 (ESPL1) used as a biomarker for patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). METHODS: 131 chronic HBV-infection patients were recruited and divided into HBV S gene integration, non-HBV S g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Rongming, Zang, Weiwei, Hu, Bobin, Deng, Deli, Ling, Xiaozhang, Zhou, Huikun, Su, Minghua, Jiang, Jianning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739072/ https://www.ncbi.nlm.nih.gov/pubmed/33308056 http://dx.doi.org/10.1177/1533033820980785

Ejemplares similares

TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer
por: Yang, Qiannan, et al.
Publicado: (2020)

ESPL1 Is a Novel Prognostic Biomarker Associated With the Malignant Features of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

ESPL1 is Elevated in Hepatocellular Carcinoma and Predicts Prognosis
por: Song, Rui, et al.
Publicado: (2022)

c-MYB is a transcriptional regulator of ESPL1/Separase in BCR-ABL-positive chronic myeloid leukemia
por: Prinzhorn, Wiltrud, et al.
Publicado: (2016)

EspL is essential for virulence and stabilizes EspE, EspF and EspH levels in Mycobacterium tuberculosis
por: Sala, Claudia, et al.
Publicado: (2018)

MMTV-Espl1 Transgenic Mice Develop Aneuploid, Estrogen Receptor Alpha (ERα)-Positive Mammary Adenocarcinomas
por: Mukherjee, Malini, et al.
Publicado: (2013)

Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancer
por: Zhong, Yuchen, et al.
Publicado: (2023)

Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Potentially Predict Response to TKI First-Line Treatment of Patients with Newly Diagnosed CML
por: Christiani, Eva, et al.
Publicado: (2023)

Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients
por: Kang, Na-Ling, et al.
Publicado: (2020)

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
por: Cho, Hyo Jung, et al.
Publicado: (2014)

Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT
por: Yan, Linlin, et al.
Publicado: (2018)

Serum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma
por: Gao, Rong, et al.
Publicado: (2015)

Evaluation of potential serum biomarkers of hepatic fibrosis and necroinflammatory activity in dogs with liver disease
por: Raghu, Chantel, et al.
Publicado: (2018)

Serum Glycopatterns as Novel Potential Biomarkers for Diagnosis of Acute-on-Chronic Hepatitis B Liver Failure
por: Zhong, Yaogang, et al.
Publicado: (2017)

Comparison of serum fibrosis biomarkers for diagnosing significant liver fibrosis in patients with chronic hepatitis B
por: Tsuji, Yuki, et al.
Publicado: (2020)

Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection
por: Qi, Peng, et al.
Publicado: (2011)

Re-Entry Evaluation of Chinese Blood Donors with Unconfirmed Hepatitis B Screening Results
por: Deng, Xuelian, et al.
Publicado: (2022)

Serum metabolite profiles are associated with the presence of advanced liver fibrosis in Chinese patients with chronic hepatitis B viral infection
por: Xie, Guoxiang, et al.
Publicado: (2020)

Identification and Validation of Novel Serum Autoantibodies Biomarkers for Staging Liver Fibrosis in Patients With Chronic Hepatitis B
por: Qi, Saiping, et al.
Publicado: (2022)

Serum interleukin-34 level can be an indicator of liver fibrosis in patients with chronic hepatitis B virus infection
por: Wang, Yin-Qiu, et al.
Publicado: (2018)

In-depth serum proteomics reveals biomarkers of psoriasis severity and response to traditional Chinese medicine
por: Xu, Meng, et al.
Publicado: (2019)

Non-ALT biomarkers for markedly abnormal liver histology among Chinese persistently normal alanine aminotransferase-chronic hepatitis B patients
por: Cheng, Jin-Lin, et al.
Publicado: (2017)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017)

Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomics
por: Zhang, Bin, et al.
Publicado: (2013)

Serum cholinesterase: A predictive biomarker of hepatic reserves in chronic hepatitis D
por: Abbas, Minaam, et al.
Publicado: (2017)

Explorative study of serum biomarkers of liver failure after liver resection
por: Yoon, Kyung Chul, et al.
Publicado: (2020)

Detection of Hepatitis B virus in serum and liver of chickens
por: Tian, Jijing, et al.
Publicado: (2012)

Liver Stiffness Measurement can Predict Liver Inflammation in Chronic Hepatitis B Patients with Normal Alanine Transaminase
por: Huang, Ling-Ling, et al.
Publicado: (2023)

Association between TLR-9 gene rs187084 polymorphism and knee osteoarthritis in a Chinese population
por: Zheng, Mingfeng, et al.
Publicado: (2017)

iTRAQ-Based Proteomics Identification of Serum Biomarkers of Two Chronic Hepatitis B Subtypes Diagnosed by Traditional Chinese Medicine
por: Yang, Jiankun, et al.
Publicado: (2016)

Serum PLR and LMR in Behçet's disease: Can they show the disease activity?
por: Jiang, Ying, et al.
Publicado: (2017)

Prognostic Value of Serum Exosomal AHCY Expression in Hepatitis B-Induced Liver Cirrhosis
por: Tong, Ling, et al.
Publicado: (2021)

Dyslipidemia and impaired liver function biomarkers in patients with hepatitis B liver cirrhosis
por: Shoaib, Naila, et al.
Publicado: (2023)

Metabolic Syndrome and Serum Liver Enzymes in the General Chinese Population
por: Chen, Shuang, et al.
Publicado: (2016)

Serum microRNA Levels as a Biomarker for Diagnosing Non-Alcoholic Fatty Liver Disease in Chinese Colorectal Polyp Patients
por: Ng, Lui, et al.
Publicado: (2023)

Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection
por: Deng, Huan, et al.
Publicado: (2020)

Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C
por: Tawara, Seiichi, et al.
Publicado: (2016)

Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis
por: Bao, Suxia, et al.
Publicado: (2017)

A Potential Serum N-glycan Biomarker for Hepatitis C Virus-Related Early-Stage Hepatocellular Carcinoma with Liver Cirrhosis
por: Higashi, Mikito, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_17ua2a0q0i3dn69shvmuqbiia6